First Page | Document Content | |
---|---|---|
![]() Date: 2016-07-02 14:50:25Health Medicine Breakthrough therapy Specialty drugs Gilead Sciences Healthcare-associated infections Cyclopropanes Sofosbuvir Ledipasvir National Institute for Health and Care Excellence Hepatitis National Health Service | Add to Reading List |
![]() | Breakthrough Cancer Therapy DTCDocID: 1sYyU - View Document |
![]() | Microsoft Word - GILEAD BRIEFINGDocID: 1r2Vm - View Document |
![]() | Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatioDocID: 1qWZQ - View Document |
![]() | 24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO BoxDocID: 1qVSm - View Document |
![]() | 12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY ODocID: 1qRuM - View Document |